tiprankstipranks
Consun Pharmaceutical Group Ltd. (DE:C1P)
:C1P
Germany Market

Consun Pharmaceutical Group Ltd. (C1P) Income Statement

Compare
2 Followers

Consun Pharmaceutical Group Ltd. Income Statement

Last quarter (Q2 2024), Consun Pharmaceutical Group Ltd.'s total revenue was ¥1.27B, an increase of 27.68% from the same quarter last year. In Q2, Consun Pharmaceutical Group Ltd.'s net income was ¥399.76M. See Consun Pharmaceutical Group Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 2.59B¥ 2.34B¥ 2.04B¥ 1.75B¥ 1.73B
Gross Profit
¥ 1.92B¥ 1.76B¥ 1.53B¥ 1.32B¥ 1.26B
Operating Expenses
¥ 1.04B¥ 1.06B¥ 857.82M¥ 744.42M¥ 1.12B
Depreciation and Amortization
¥ 78.09M¥ 76.36M¥ 72.99M¥ 71.80M¥ 73.11M
EBITDA
¥ 963.06M¥ 785.89M¥ 728.71M¥ 618.79M¥ 566.36M
Operating Income
¥ 884.97M¥ 715.41M¥ 660.18M¥ 550.13M¥ 496.38M
Other Income/Expenses
¥ -21.26M¥ 30.98M¥ 35.68M¥ 33.61M¥ -29.04M
Pretax Income
¥ 863.70M¥ 746.39M¥ 695.86M¥ 583.74M¥ 133.66M
Net Income
¥ 784.53M¥ 682.91M¥ 590.17M¥ 498.79M¥ 79.82M
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 0.98¥ 0.86¥ 0.74¥ 0.61¥ 0.09
Diluted EPS
¥ 0.98¥ 0.86¥ 0.73¥ 0.61¥ 0.09
Weighted Average Shares Outstanding
800.54M 790.63M 801.58M 817.26M 848.77M
Weighted Average Shares Outstanding (Diluted)
799.17M 792.00M 804.70M 817.26M 854.47M
Currency in CNY

Consun Pharmaceutical Group Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis